Metastatic renal cell carcinoma

Metastatic renal cell carcinoma is an advanced malignancy arising from the renal tubular epithelium that has disseminated beyond the kidney and Gerota’s fascia to distant anatomical sites Predominantly affecting adults and most commonly exhibiting clear cell histology, the disease spreads hematogenously and lymphatically, with frequent metastases to the lungs, bone, liver, brain, and distant lymph nodes

Metastatic renal cell carcinoma is an advanced malignancy arising from the renal tubular epithelium that has disseminated beyond the kidney and Gerota’s fascia to distant anatomical sites Predominantly affecting adults and most commonly exhibiting clear cell histology, the disease spreads hematogenously and lymphatically, with frequent metastases to the lungs, bone, liver, brain, and distant lymph nodes

Predominantly affecting adults and most commonly exhibiting clear cell histology, the disease spreads hematogenously and lymphatically, with frequent metastases to the lungs, bone, liver, brain, and distant lymph nodes Clinically, it may manifest with localized symptoms such as flank pain and hematuria, site-specific metastatic complications, or systemic paraneoplastic phenomena including hypercalcemia and cachexia

Pathophysiologically, it is often driven by dysregulation of the von Hippel-Lindau pathway, leading to vascular endothelial growth factor accumulation, intense angiogenesis, and pronounced resistance to standard cytotoxic chemotherapy

Pathophysiologically, it is often driven by dysregulation of the von Hippel-Lindau pathway, leading to vascular endothelial growth factor accumulation, intense angiogenesis, and pronounced resistance to standard cytotoxic chemotherapy

Clinically, it may manifest with localized symptoms such as flank pain and hematuria, site-specific metastatic complications, or systemic paraneoplastic phenomena including hypercalcemia and cachexia

Clinically, it may manifest with localized symptoms such as flank pain and hematuria, site-specific metastatic complications, or systemic paraneoplastic phenomena including hypercalcemia and cachexia